# IOMED Medical Solutions S.L.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/iomed-medical-solutions-s-l

- Industry: Healthcare IT
- Headquarters: Barcelona, Spain
- Website: www.iomed.es
- Total disclosed funding: $11M
- Latest round: Series A (Sep 12, 2023)
- Investors on record: 9

## About

IOMED Medical Solutions S.L., based in Spain, specializes in leveraging artificial intelligence and data management solutions to enhance the compliance and secondary use of health data across healthcare organizations and clinical research.Founded in 2016 in Barcelona, Spain, IOMED Medical Solutions S.L. focuses on enabling healthcare organizations to manage health data efficiently. The company has participated in 6 investment deals, with the most recent funding round occurring on September 12, 2023, where they raised EUR 10 million in a SERIES A round led by Philips Health Technology Ventures and XTX Ventures, along with participation from Adara Ventures, RedSeed Ventures, and returning investors. The company was founded by Gabriel Maeztu, Javier de, and Álvaro Bascarán, with Javier de currently serving as the CEO.IOMED specializes in a Data Space Platform that utilizes artificial intelligence to facilitate the compliant secondary use of health data. Their services include Data Space Enablement, which partners with data holders to maintain a comprehensive overview of patient data, and Data Space Mediation, connecting data holders with users to optimize data utilization across IOMED’s federated network. The platform serves a diverse client base, including over 50 strategic partners and healthcare institutions across Europe, with a focus on enhancing patient outcomes and supporting clinical research.In the most recent year, 2022, IOMED reported revenue of EUR 494,646.80 and an EBITDA of EUR -333,331. The company generates revenue through partnerships and subscriptions related to its Data Space Platform, where clients access the platform under negotiated terms including ongoing subscription fees and project-based pricing.Following the EUR 10 million raised in SERIES A funding in September 2023, IOMED plans to enhance its AI-powered technology for healthcare data activation. The company aims to expand its market presence in Europe, particularly within healthcare and clinical research sectors, to better serve their clients. This investment will support the development of new products and services aimed at optimizing health data management, enhancing their offerings to current and future partners.

## Funding rounds

- Series A, Sep 12, 2023, $11M — Adara Ventures, Inveready Asset Management, RedSeed Ventures, XTX Ventures, Afi Inversiones Globales, Philips Health Technology Ventures
- Seed, Jul 16, 2018, $0.6M — Inveready Asset Management, Speedinvest, Pioneers Ventures, Easo Ventures

## Investors

- Inveready Asset Management (https://capitalatlas.ai/funds/inveready-asset-management) — Seed, Series A
- Speedinvest (https://capitalatlas.ai/funds/speedinvest) — Seed
- Pioneers Ventures (https://capitalatlas.ai/funds/pioneers-ventures) — Seed
- Easo Ventures — Seed
- Adara Ventures (https://capitalatlas.ai/funds/adara-ventures) — Series A
- RedSeed Ventures (https://capitalatlas.ai/funds/redseed-ventures) — Series A
- XTX Ventures (https://capitalatlas.ai/funds/xtx-ventures) — Series A
- Afi Inversiones Globales (https://capitalatlas.ai/funds/afi-inversiones-globales) — Series A
- Philips Health Technology Ventures (https://capitalatlas.ai/funds/philips-health-technology-ventures) — Series A